Stay updated on Pembrolizumab + Ibrutinib in Stage III-IV Melanoma Clinical Trial

Sign up to get notified when there's something new on the Pembrolizumab + Ibrutinib in Stage III-IV Melanoma Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Pembrolizumab + Ibrutinib in Stage III-IV Melanoma Clinical Trial page

  1. Check
    4 days ago
    No Change Detected
  2. Check
    11 days ago
    No Change Detected
  3. Check
    18 days ago
    Change Detected
    Summary
    The site footer revision number was updated from v3.5.2 to v3.5.3, indicating a website/version refresh without changing the trial details.
    Difference
    0.1%
    Check dated 2026-04-24T16:52:21.000Z thumbnail image
  4. Check
    26 days ago
    Change Detected
    Summary
    Revision updated from v3.5.0 to v3.5.2.
    Difference
    0.1%
    Check dated 2026-04-17T13:38:26.000Z thumbnail image
  5. Check
    54 days ago
    Change Detected
    Summary
    Revision label updated to v3.5.0, replacing v3.4.3. This appears to be an internal version update with no changes to the study content.
    Difference
    0.1%
    Check dated 2026-03-19T22:14:14.000Z thumbnail image
  6. Check
    61 days ago
    Change Detected
    Summary
    Page revision updated from v3.4.2 to v3.4.3.
    Difference
    0.1%
    Check dated 2026-03-12T19:45:18.000Z thumbnail image
  7. Check
    90 days ago
    Change Detected
    Summary
    The revision label was updated from v3.4.1 to v3.4.2. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.1%
    Check dated 2026-02-12T01:54:18.000Z thumbnail image
  8. Check
    97 days ago
    Change Detected
    Summary
    Page revision updated from v3.4.0 to v3.4.1. No changes to study content or eligibility criteria are indicated.
    Difference
    0.1%
    Check dated 2026-02-04T23:34:02.000Z thumbnail image

Stay in the know with updates to Pembrolizumab + Ibrutinib in Stage III-IV Melanoma Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Pembrolizumab + Ibrutinib in Stage III-IV Melanoma Clinical Trial page.